Search Results 71-80 of 20570 for colitis
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis · Overview · Participation eligibility.
Research. Mayo Clinic researchers are working to improve the understanding and treatment of microscopic colitis. Efforts have included studies of clinical ...
This study is an open label, long-term extension study for subjects with moderate to severe ulcerative colitis designed to evaluate long term therapy of CP- ...
There are two common types: ulcerative colitis, which causes ulcers, or sores, in the lining of the large intestine and rectum, and Crohn's disease, which ...
... colitis This protein can be measured in stool, which gives physicians a proxy of how much inflammation is occurring in the bowel. This multicentered study ...
This type of inflammatory bowel disease causes swelling and sores in the digestive tract. Learn more about symptoms and treatment.
About this study. The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC).
The purpose of this study is to determine safety and tolerability of orally delivered R-3750 in mild to moderate patients with ulcerative colitis.
The pouch is made to treat a bowel disease called ulcerative colitis and some other diseases. Many people with ulcerative colitis need to have their colons ...
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis · Share · Facebook · Twitter.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.